P-295. Association of HIV Pre-exposure Prophylaxis (PrEP) Initiation and Persistence with Prior Visit with the PrEP Prescriber among Cisgender Women in the Bronx, NY, 2012-2023

Open Forum Infectious Diseases 2026 Open access

Read full text
Authors: Cristal L. Finkenberg, Caroline E. Mullis, Marla J. Keller, Uriel R. Felsen, Jessica McWalters, Martin F Packer
DOI: 10.1093/ofid/ofaf695.516
Cited by: 0

Abstract

Abstract Background Pre-exposure prophylaxis (PrEP) is an effective, user-controlled HIV prevention strategy, but uptake and persistence are low in cisgender women (CGW) [1-8]. Providers have a crucial role in supporting PrEP use, and a preexisting patient-provider relationship may support PrEP initiation and persistence.Table 1.Factors Associated with PrEP Initiation and at least 3-month Persistence Among CGWSignificant differences in PrEP initiation (p

Fields of Study & Subjects

HIV/AIDS Research and Interventions HIV Drug Use Sexual Risk HIV/AIDS drug development and treatment

Publication details

Journal / source
Open Forum Infectious Diseases
Volume
13
Issue
Supplement_1
Publication date
1 January 2026
Language
EN